Thurston, Springer, Miller, Herd & Titak, Inc. Novo Nordisk A S Transaction History
Thurston, Springer, Miller, Herd & Titak, Inc.
- $558 Million
- Q1 2025
A detailed history of Thurston, Springer, Miller, Herd & Titak, Inc. transactions in Novo Nordisk A S stock. As of the latest transaction made, Thurston, Springer, Miller, Herd & Titak, Inc. holds 928 shares of NVO stock, worth $63,660. This represents 0.01% of its overall portfolio holdings.
Number of Shares
928
Previous 785
18.22%
Holding current value
$63,660
Previous $67,000
4.48%
% of portfolio
0.01%
Previous 0.01%
Shares
4 transactions
Others Institutions Holding NVO
# of Institutions
1,769Shares Held
330MCall Options Held
11.3MPut Options Held
15.5M-
Jennison Associates LLC18.8MShares$1.29 Billion0.93% of portfolio
-
Bank Of America Corp Charlotte, NC14.8MShares$1.01 Billion0.08% of portfolio
-
Loomis Sayles & CO L P12.4MShares$850 Million1.24% of portfolio
-
Morgan Stanley New York, NY12.3MShares$845 Million0.06% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa11.9MShares$814 Million0.36% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $155B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...